JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 25 No. 8 859-864
© 1984 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenbaum, R. C.
Right arrow Articles by Metcalfe, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenbaum, R. C.
Right arrow Articles by Metcalfe, D. D.

Patterns of Skeletal Scintigraphy and Their Relationship to Plasma and Urinary Histamine Levels in Systemic Mastocytosis

Richard C. Rosenbaum*, Marianne Frieri and Dean D. Metcalfe

National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

Correspondence: For reprints contact: Dean D. Metcalfe, MD, Building 10, Rm 11C-210, National Institutes of Health, Bethesda, MD 20205.

ABSTRACT

Scintigraphic findings in ten cases of systemic mastocytosis are described. Four radionuclide bone patterns were noted: normal, unifocal, multifocal, and diffuse. Compared with radiographic surveys, bone images were better able to show the widespread skeletal involvement in patients with diffuse disease, and to detect a greater number of focal lesions. Serum calcium, phosphorus, and hydroxyproline levels, were usually within normal limits even when the bone scintigrams were clearly abnormal. Plasma and urinary histamine levels were highest in patients whose bone images detected widespread skeletal involvement. In systemic mastocytosis, not only does scintigraphy document active bone disease more effectively than laboratory studies of bone metabolism and radiographs of bone, but it also appears to reflect the general severity of the disease process.

FOOTNOTES

* Present address: Dept. of Diagnostic Radiology, University of Maryland Hospital, Baltimore, MD 21201.




This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
G. Zettinig, A. Becherer, M. Szabo, M. Uffmann, R. Dudczak, P. Valent, and K. Kletter
FDG Positron Emission Tomography in Patients with Systemic Mastocytosis
Am. J. Roentgenol., November 1, 2002; 179(5): 1235 - 1237.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1984 by the Society of Nuclear Medicine.